GLP-1 TirzepatideRx

All-in monthly price at 10 mg — medication plus any membership fee

Home Guides Tirzepatide Without Insurance

Tirzepatide Without Insurance: The Cheapest Legitimate Routes in 2026

Without insurance, compounded tirzepatide from a licensed US 503A pharmacy runs roughly $99–$299 per month. Brand-name Zepbound through LillyDirect self-pay runs $299–$449. Retail Zepbound w…

5 mg

Short answer

Without insurance, compounded tirzepatide from a licensed US 503A pharmacy runs roughly $99–$299 per month. Brand-name Zepbound through LillyDirect self-pay runs $299–$449. Retail Zepbound without any program runs around $1,089.

Start by confirming you are actually uninsured for this

A surprising number of people paying cash have coverage they have not tested. Plans that exclude 'weight loss' often cover the same drug for obstructive sleep apnea, and Zepbound carries a specific FDA indication for moderate-to-severe OSA with obesity. If you snore heavily, wake unrefreshed or have been told you stop breathing at night, a sleep study is worth more than a coupon.

Compounded, ranked by real twelve-month cost

Ignore the advertised entry price and compare what each program charges at 10 mg — the dose most people settle at. A flat-rate program at $179 beats a $129 program that reaches $299 by month four. Our calculator does this arithmetic for you.

Also check whether the price includes shipping, the clinician consultation and refills, or whether those are billed separately. On the programs we track, most quote all-in, but not all do.

HSA and FSA funds

Weight-management medication prescribed by a clinician is generally an eligible expense. Compounded medications usually qualify, but some administrators require a letter of medical necessity. Keep every receipt and get the letter before you need it.

What to avoid entirely

Peptide sellers labeling product 'for research use only'. Any site that ships without a prescription. Overseas vendors with no US pharmacy license. Prices well below the $99 floor — at that point somebody is cutting a corner you cannot see, and the corner is usually the active ingredient's provenance.

Price your actual dose

Six dose tiers, sixteen tracked programs, twelve-month totals.

Open the calculator

Common questions

What are the most common tirzepatide side effects?

Nausea (roughly 24–33%), diarrhea (19–23%), constipation (16–17%) and vomiting (8–12%). They cluster in the days after each dose increase and usually settle within one to two weeks at each new dose. Constipation is the one that most often persists.

Do I need a prescription for tirzepatide?

Yes, always — for brand and compounded alike. Any seller shipping tirzepatide without a prescription from a licensed prescriber is operating illegally, and the product should not be considered pharmaceutical grade.

Can I switch from semaglutide to tirzepatide without starting over?

You restart at 2.5 mg tirzepatide regardless of your semaglutide dose, because there is no equivalence between the molecules. Most switchers find re-titration far easier than a first start — roughly 13% report GI symptoms — because GLP-1 receptor adaptation carries over. Take the first tirzepatide dose about seven days after your last semaglutide injection.

Why is some tirzepatide advertised under $100 a month?

Usually one of four reasons: it is the 2.5 mg starter-tier price only, it is an introductory rate that reverts, there is a separate membership fee, or the product is not from a licensed US pharmacy. Ask what you will pay at 10 mg before you enrol.

People also ask about tirzepatide without insurance

What is tirzepatide without insurance?

Tirzepatide without insurance is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.

Does tirzepatide without insurance apply to compounded tirzepatide as well as Zepbound?

The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.

How much does tirzepatide without insurance cost per month in 2026?

Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.

Is tirzepatide without insurance FDA-approved?

Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.

Primary sources

Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.

  1. ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
  2. FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
  3. FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
  4. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
  5. The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.